aTyr Pharma, Inc. (LIFE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 108.71M |
| Enterprise Value | 25.63M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 242.98 |
| Price/Book (mrq) | 1.20 |
| Enterprise Value/Revenue | 72.62 |
| Enterprise Value/EBITDA | -0.49 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.23 |
| 52-Week Change 3 | -19.60% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 2.7000 |
| 52 Week Low 3 | 1.0800 |
| 50-Day Moving Average 3 | 1.8165 |
| 200-Day Moving Average 3 | 1.6226 |
Share Statistics
| Avg Vol (3 month) 3 | 556.81k |
| Avg Vol (10 day) 3 | 294.27k |
| Shares Outstanding 5 | 67.94M |
| Implied Shares Outstanding 6 | 68.79M |
| Float 8 | 60.12M |
| % Held by Insiders 1 | 2.62% |
| % Held by Institutions 1 | 61.91% |
| Shares Short (Mar 28, 2024) 4 | 436.89k |
| Short Ratio (Mar 28, 2024) 4 | 0.62 |
| Short % of Float (Mar 28, 2024) 4 | 0.91% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 0.64% |
| Shares Short (prior month Feb 29, 2024) 4 | 108.23k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jul 01, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:14 |
| Last Split Date 3 | Jul 01, 2019 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -15,557.79% |
Management Effectiveness
| Return on Assets (ttm) | -31.72% |
| Return on Equity (ttm) | -62.31% |
Income Statement
| Revenue (ttm) | 353k |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | -100.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -54.33M |
| Net Income Avi to Common (ttm) | -50.39M |
| Diluted EPS (ttm) | -0.9400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 98.17M |
| Total Cash Per Share (mrq) | 1.45 |
| Total Debt (mrq) | 15.1M |
| Total Debt/Equity (mrq) | 16.69% |
| Current Ratio (mrq) | 6.27 |
| Book Value Per Share (mrq) | 1.43 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33.22M |
| Levered Free Cash Flow (ttm) | -21.18M |
© 2024 Yahoo. All rights reserved.